PDB21 A COST-UTILITY ANALYSIS OF INSULIN GLARGINE (LANTUS) IN THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61744-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)61744-5/fulltext
Section Title :
Section Order :
189
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61744-5&doi=10.1016/S1098-3015(10)61744-5